These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Early and late stage gene therapy interventions for inherited retinal degenerations. Botto C; Rucli M; Tekinsoy MD; Pulman J; Sahel JA; Dalkara D Prog Retin Eye Res; 2022 Jan; 86():100975. PubMed ID: 34058340 [TBL] [Abstract][Full Text] [Related]
23. Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration. Wood EH; Kreymerman A; Kowal T; Buickians D; Sun Y; Muscat S; Mercola M; Moshfeghi DM; Goldberg JL Prog Retin Eye Res; 2023 Sep; 96():101153. PubMed ID: 36503723 [TBL] [Abstract][Full Text] [Related]
24. Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice. van Wyk M; Schneider S; Kleinlogel S Mol Vis; 2015; 21():811-27. PubMed ID: 26283863 [TBL] [Abstract][Full Text] [Related]
25. Optogenetics for retinal disorders. Henriksen BS; Marc RE; Bernstein PS J Ophthalmic Vis Res; 2014; 9(3):374-82. PubMed ID: 25667740 [TBL] [Abstract][Full Text] [Related]
31. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions. Ganjawala TH; Pan ZH Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746 [TBL] [Abstract][Full Text] [Related]
32. Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy. De Silva SR; Barnard AR; Hughes S; Tam SKE; Martin C; Singh MS; Barnea-Cramer AO; McClements ME; During MJ; Peirson SN; Hankins MW; MacLaren RE Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11211-11216. PubMed ID: 28973921 [TBL] [Abstract][Full Text] [Related]
33. Gene therapy in inherited retinal degenerative diseases, a review. Takahashi VKL; Takiuti JT; Jauregui R; Tsang SH Ophthalmic Genet; 2018 Oct; 39(5):560-568. PubMed ID: 30040511 [TBL] [Abstract][Full Text] [Related]
34. A Systematic Review of Optogenetic Vision Restoration: History, Challenges, and New Inventions from Bench to Bedside. Stefanov A; Flannery JG Cold Spring Harb Perspect Med; 2023 Jun; 13(6):. PubMed ID: 36376079 [TBL] [Abstract][Full Text] [Related]
35. Losing, preserving, and restoring vision from neurodegeneration in the eye. Kerschensteiner D Curr Biol; 2023 Oct; 33(19):R1019-R1036. PubMed ID: 37816323 [TBL] [Abstract][Full Text] [Related]
36. Restoring the ON Switch in Blind Retinas: Opto-mGluR6, a Next-Generation, Cell-Tailored Optogenetic Tool. van Wyk M; Pielecka-Fortuna J; Löwel S; Kleinlogel S PLoS Biol; 2015 May; 13(5):e1002143. PubMed ID: 25950461 [TBL] [Abstract][Full Text] [Related]
37. Overview on Research and Clinical Applications of Optogenetics. Towne C; Thompson KR Curr Protoc Pharmacol; 2016 Dec; 75():11.19.1-11.19.21. PubMed ID: 27960028 [TBL] [Abstract][Full Text] [Related]
38. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases. Yan B; Nirenberg S IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684 [TBL] [Abstract][Full Text] [Related]
39. Functional interrogation of neural circuits with virally transmitted optogenetic tools. De La Crompe B; Coulon P; Diester I J Neurosci Methods; 2020 Nov; 345():108905. PubMed ID: 32795553 [TBL] [Abstract][Full Text] [Related]